ADAMTS-13 activity can predict the outcome of disseminated intravascular coagulation in hematologic malignancies treated with recombinant human soluble thrombomodulin.
Ohshiro M, Kuroda J, Kobayashi Y, Akaogi T, Kawata E, Uoshima N, Kamitsuji Y, Kaneko H, Shimura K, Shimazaki C, Murakami S, Hatsuse M, Okano A, Kobayashi T, Uchiyama H, Matsumoto Y, Horiike S, Taniwaki M.
Ohshiro M, et al. Among authors: horiike s.
Am J Hematol. 2012 Jan;87(1):116-9. doi: 10.1002/ajh.22185. Epub 2011 Oct 12.
Am J Hematol. 2012.
PMID: 21989545
Free article.
Clinical Trial.
No abstract available.